Cure My Disease

Don't miss your cure!

 Log in / Sign up

New peptide cream promises better skin hydration – but is it hype?

NCT ID NCT07236736

Symptom relief Sponsor: Biocoz Global Pte. Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a topical cream called SPM™ on 10 healthy adults to see if it improves skin hydration, appearance, and barrier function. Participants apply the cream twice daily for six weeks on one area, while an untreated area serves as a comparison. Skin hydration and small biopsies are taken before and after to look for changes in skin structure and moisture.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Super Protein Multifunction (SPM™) topical peptide-based formulation
What this could lead to
If it works, this could point toward a cosmetic product that improves skin hydration and barrier strength.
What could go wrong
This is a very small, early exploratory study with only 10 healthy adults. It is not designed to prove effectiveness, and results may not apply to people with skin conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Generally healthy with no systemic or active dermatologic diseases. 2. Willing and able to apply topical product daily for 6 weeks. 3. Able to provide written informed consent. 4. Willing to undergo skin biopsies and follow study procedures. Exclusion Criteria: 1. History of skin cancer or other malignancy within the past 10 years. 2. Active or chronic dermatologic conditions (e.g., eczema, psoriasis, acne, rosacea). 3. Known allergy or sensitivity to components of the investigational product. 4. Current use of systemic corticosteroids or immunosuppressants. 5. Pregnancy or breastfeeding. 6. Any condition that, in the investigator's opinion, would interfere with study participation or pose additional risk.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy skin are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy skin Skin hydration

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Project Quality of Life

    West Hollywood, California, 90069, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.